Komatsu Masamichi, Yamamoto Hiroshi, Shomura Toshitaka, Sonehara Kei, Ichiyama Takashi, Urushihata Kazuhisa, Ushiki Atsuhito, Yasuo Masanori, Wakamatsu Toshihide, Sugimoto Seiichiro, Oto Takahiro, Date Hiroshi, Koizumi Tomonobu, Hanaoka Masayuki, Kubo Keishi
The First Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Department of Organ Transplant Center, Okayama University Hospital, Japan.
Intern Med. 2019 Nov 1;58(21):3133-3137. doi: 10.2169/internalmedicine.3160-19. Epub 2019 Jul 10.
Patients with end-stage lung disease can undergo living-donor lobar lung transplantation (LDLLT), with survival rates improving every year. We herein report the 20-year follow-up findings of the first patient who underwent LDLLT in Japan. A 24-year-old woman with primary ciliary dyskinesia became ventilator-dependent after severe respiratory failure and right-sided heart failure following repeated respiratory infections. In 1998, she underwent LDLLT and received her sister's right lower lobe and her mother's left lower lobe. Although the patient required 21 hospitalizations and developed unilateral bronchiolitis obliterans syndrome, she is in good physical condition and lives without restriction at 20 years after undergoing LDLLT.
终末期肺病患者可接受活体供体肺叶移植(LDLLT),其生存率逐年提高。我们在此报告日本首例接受LDLLT患者的20年随访结果。一名24岁患有原发性纤毛运动障碍的女性,在反复呼吸道感染后出现严重呼吸衰竭和右侧心力衰竭,之后依赖呼吸机。1998年,她接受了LDLLT,接受了来自其姐姐的右下叶和母亲的左下叶。尽管该患者需要住院21次,并出现了单侧闭塞性细支气管炎综合征,但她身体状况良好,在接受LDLLT 20年后生活不受限制。